The Cigna Group (CI)

Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell

$318.16

Buy

$342.66

arrow-up$0.35 (+0.11%)

Cigna Corp operates in the healthcare industry. It provides medical, dental, disability, life and accident insurance products.
Prices updated at 10 May 2025, 00:01 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.07%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Healthcare Plans
Chairman
Mr. David M. Cordani
CEO
Mr. David M. Cordani
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
73,500
Head office
900 Cottage Grove Road
Bloomfield
United States
06002
mobile
+1 860 226-6000
letter
william.mcdowell2@cigna.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Ms. Ann M. Dennison
Executive Vice President and Chief Financial Officer
-----
Ms. Noelle K. Eder
Executive Vice President and Global Chief Information Officer
0.87m--5.79m-
Mr. Brian C. Evanko
President and Chief Operating Officer
0.99m--10.28m-
Mr. David M. Cordani
Chairman of the Board, President and Chief Executive Officer
1.57m--23.25m-
Ms. Donna F. Zarcone
Independent Director
0.15m--0.34m-
Mr. Eric C. Wiseman
Lead Independent Director
0.18m--0.37m-
Dr. David J. Brailer, M.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
-----
Mr. Eric J. Foss
Independent Director
0.15m--0.34m-
Ms. Nicole S. Jones
Executive Vice President, Chief Administrative Officer, and General Counsel
0.87m--5.79m-
Ms. Kimberly A. Ross
Independent Director
0.15m--0.34m-
Dr. Mark B. McClellan, M.D.,PhD
Independent Director
0.12m--0.31m-
Mr. George Kurian
Independent Director
0.12m--0.31m-
Dr. Elder Granger, M.D.
Independent Director
0.15m--0.34m-
Ms. Kathleen M. Mazzarella
Independent Director
0.15m--0.34m-
Ms. Neesha Hathi
Independent Director
0.12m--0.31m-
Dr. Philip O. Ozuah, M.D.,PhD
Independent Director
0.12m--0.31m-
Ms. Jamie Kates
Vice President and Global Chief Accounting Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc26,108,9540.12558177240.06793130 Apr 20259.77
BlackRock Inc23,883,0220.13345-751711-3.05142730 Apr 20258.94
FMR LLC14,193,987--327170-2.25305730 Apr 20255.10
State Street Corp12,719,6130.13857-105728-0.82436830 Apr 20254.76
FMR Inc12,465,4810.20543-1764916-12.40243730 Apr 20254.67

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
29 Nov 2024-Mr. Eric C. Wiseman337.8045,6038,236--
29 Nov 2024-Mr. George Kurian337.8029,7261,263--
15 Nov 2024-Mr. Eric P. Palmer--54,273--
30 Aug 2024-Mr. Eric C. Wiseman361.8145,5888,069--
30 Aug 2024-Dr. David J. Brailer, M.D.361.22104,7549,042--
30 Aug 2024-Mr. George Kurian361.8129,6681,170--
19 Aug 2024-Mr. William J. Delaney342.68922,15217,539--
19 Aug 2024-Mr. William J. Delaney-----
19 Aug 2024-Mr. William J. Delaney175.09471,17720,230--
12 Aug 2024-Ms. Nicole S. Jones330.967,291,04924,587--
13 Aug 2024-Ms. Nicole S. Jones-----
12 Aug 2024-Ms. Nicole S. Jones--2,636--
13 Aug 2024-Ms. Nicole S. Jones149.13393,12027,223--
12 Aug 2024-Ms. Nicole S. Jones149.132,241,49946,617--
12 Aug 2024-Mr. Michael W. Triplett330.96590,76437,867--
12 Aug 2024-Mr. Michael W. Triplett--2,506--
12 Aug 2024-Mr. Michael W. Triplett329.581,659,08832,833--
12 Aug 2024-Mr. Michael W. Triplett149.131,073,77239,652--
24 Jun 2024-Mr. Brian C. Evanko120.89579,69244,718--
25 Jun 2024-Mr. Brian C. Evanko-----
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.